nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—MTHFR—Parkinson's disease	0.508	0.758	CbGaD
Methotrexate—ABCB1—Parkinson's disease	0.162	0.242	CbGaD
Methotrexate—ATIC—pes—Parkinson's disease	0.0136	0.105	CbGeAlD
Methotrexate—ATIC—forelimb—Parkinson's disease	0.00686	0.0529	CbGeAlD
Methotrexate—SLC19A1—tongue—Parkinson's disease	0.00569	0.0439	CbGeAlD
Methotrexate—ABCC11—embryo—Parkinson's disease	0.00298	0.023	CbGeAlD
Methotrexate—ATIC—embryo—Parkinson's disease	0.00176	0.0136	CbGeAlD
Methotrexate—Tetrahydrofolic acid—MTHFR—Parkinson's disease	0.00162	0.383	CrCbGaD
Methotrexate—Folic Acid—MTHFR—Parkinson's disease	0.00162	0.383	CrCbGaD
Methotrexate—ATIC—brainstem—Parkinson's disease	0.00161	0.0124	CbGeAlD
Methotrexate—FOLR1—head—Parkinson's disease	0.00158	0.0121	CbGeAlD
Methotrexate—ATIC—forebrain—Parkinson's disease	0.00156	0.012	CbGeAlD
Methotrexate—FOLR1—central nervous system—Parkinson's disease	0.00144	0.0111	CbGeAlD
Methotrexate—FOLR1—cerebellum—Parkinson's disease	0.00141	0.0108	CbGeAlD
Methotrexate—SLC19A1—head—Parkinson's disease	0.00138	0.0107	CbGeAlD
Methotrexate—GGH—medulla oblongata—Parkinson's disease	0.00132	0.0102	CbGeAlD
Methotrexate—ATIC—cardiovascular system—Parkinson's disease	0.00132	0.0101	CbGeAlD
Methotrexate—SLC19A1—nervous system—Parkinson's disease	0.00131	0.0101	CbGeAlD
Methotrexate—SLCO1C1—forebrain—Parkinson's disease	0.00129	0.00997	CbGeAlD
Methotrexate—SLC19A1—central nervous system—Parkinson's disease	0.00126	0.00972	CbGeAlD
Methotrexate—SLC19A1—cerebellum—Parkinson's disease	0.00123	0.0095	CbGeAlD
Methotrexate—GGH—midbrain—Parkinson's disease	0.00121	0.00931	CbGeAlD
Methotrexate—SLC46A1—spinal cord—Parkinson's disease	0.0012	0.00923	CbGeAlD
Methotrexate—DHFR—embryo—Parkinson's disease	0.00118	0.0091	CbGeAlD
Methotrexate—GGH—spinal cord—Parkinson's disease	0.00118	0.00908	CbGeAlD
Methotrexate—FPGS—medulla oblongata—Parkinson's disease	0.00116	0.00896	CbGeAlD
Methotrexate—MTHFR—forebrain—Parkinson's disease	0.00116	0.00891	CbGeAlD
Methotrexate—FOLR1—brain—Parkinson's disease	0.00114	0.0088	CbGeAlD
Methotrexate—SLC46A1—head—Parkinson's disease	0.00107	0.00821	CbGeAlD
Methotrexate—GGH—head—Parkinson's disease	0.00105	0.00807	CbGeAlD
Methotrexate—FPGS—spinal cord—Parkinson's disease	0.00104	0.00799	CbGeAlD
Methotrexate—ATIC—midbrain—Parkinson's disease	0.00103	0.00792	CbGeAlD
Methotrexate—SLC46A1—nervous system—Parkinson's disease	0.00101	0.00778	CbGeAlD
Methotrexate—PGD—forebrain—Parkinson's disease	0.001	0.00774	CbGeAlD
Methotrexate—ATIC—spinal cord—Parkinson's disease	0.001	0.00772	CbGeAlD
Methotrexate—SLC19A1—brain—Parkinson's disease	0.001	0.00772	CbGeAlD
Methotrexate—GGH—nervous system—Parkinson's disease	0.000993	0.00765	CbGeAlD
Methotrexate—Folic Acid—CYP2E1—Parkinson's disease	0.000987	0.233	CrCbGaD
Methotrexate—MTHFR—cardiovascular system—Parkinson's disease	0.000978	0.00753	CbGeAlD
Methotrexate—SLC46A1—central nervous system—Parkinson's disease	0.000972	0.00749	CbGeAlD
Methotrexate—GGH—central nervous system—Parkinson's disease	0.000956	0.00737	CbGeAlD
Methotrexate—SLC46A1—cerebellum—Parkinson's disease	0.00095	0.00732	CbGeAlD
Methotrexate—GGH—cerebellum—Parkinson's disease	0.000935	0.0072	CbGeAlD
Methotrexate—FPGS—head—Parkinson's disease	0.000921	0.0071	CbGeAlD
Methotrexate—ATIC—head—Parkinson's disease	0.000891	0.00686	CbGeAlD
Methotrexate—DHFR—cardiovascular system—Parkinson's disease	0.000883	0.00681	CbGeAlD
Methotrexate—FPGS—nervous system—Parkinson's disease	0.000873	0.00673	CbGeAlD
Methotrexate—SLCO1C1—midbrain—Parkinson's disease	0.000854	0.00658	CbGeAlD
Methotrexate—PGD—cardiovascular system—Parkinson's disease	0.000849	0.00654	CbGeAlD
Methotrexate—ATIC—nervous system—Parkinson's disease	0.000845	0.00651	CbGeAlD
Methotrexate—FPGS—central nervous system—Parkinson's disease	0.000841	0.00648	CbGeAlD
Methotrexate—SLCO1C1—spinal cord—Parkinson's disease	0.000833	0.00642	CbGeAlD
Methotrexate—SLCO3A1—medulla oblongata—Parkinson's disease	0.000822	0.00633	CbGeAlD
Methotrexate—FPGS—cerebellum—Parkinson's disease	0.000822	0.00633	CbGeAlD
Methotrexate—ATIC—central nervous system—Parkinson's disease	0.000813	0.00627	CbGeAlD
Methotrexate—ATIC—cerebellum—Parkinson's disease	0.000795	0.00612	CbGeAlD
Methotrexate—SLC16A1—cardiovascular system—Parkinson's disease	0.000793	0.00611	CbGeAlD
Methotrexate—SLC46A1—brain—Parkinson's disease	0.000772	0.00595	CbGeAlD
Methotrexate—GGH—brain—Parkinson's disease	0.000759	0.00585	CbGeAlD
Methotrexate—DHFR—medulla oblongata—Parkinson's disease	0.000755	0.00582	CbGeAlD
Methotrexate—SLCO3A1—midbrain—Parkinson's disease	0.000751	0.00579	CbGeAlD
Methotrexate—SLCO1A2—forebrain—Parkinson's disease	0.000742	0.00572	CbGeAlD
Methotrexate—SLCO1C1—head—Parkinson's disease	0.000741	0.00571	CbGeAlD
Methotrexate—SLCO3A1—spinal cord—Parkinson's disease	0.000733	0.00565	CbGeAlD
Methotrexate—PGD—medulla oblongata—Parkinson's disease	0.000726	0.00559	CbGeAlD
Methotrexate—ABCC4—forebrain—Parkinson's disease	0.000714	0.0055	CbGeAlD
Methotrexate—SLCO1C1—nervous system—Parkinson's disease	0.000702	0.00541	CbGeAlD
Methotrexate—TYMS—midbrain—Parkinson's disease	0.000697	0.00537	CbGeAlD
Methotrexate—DHFR—midbrain—Parkinson's disease	0.00069	0.00532	CbGeAlD
Methotrexate—SLC16A1—medulla oblongata—Parkinson's disease	0.000677	0.00522	CbGeAlD
Methotrexate—SLCO1C1—central nervous system—Parkinson's disease	0.000676	0.00521	CbGeAlD
Methotrexate—DHFR—spinal cord—Parkinson's disease	0.000673	0.00519	CbGeAlD
Methotrexate—FPGS—brain—Parkinson's disease	0.000668	0.00514	CbGeAlD
Methotrexate—PGD—midbrain—Parkinson's disease	0.000663	0.00511	CbGeAlD
Methotrexate—MTHFR—head—Parkinson's disease	0.000662	0.0051	CbGeAlD
Methotrexate—SLCO3A1—head—Parkinson's disease	0.000652	0.00502	CbGeAlD
Methotrexate—PGD—spinal cord—Parkinson's disease	0.000647	0.00499	CbGeAlD
Methotrexate—ATIC—brain—Parkinson's disease	0.000646	0.00497	CbGeAlD
Methotrexate—MTHFR—nervous system—Parkinson's disease	0.000628	0.00484	CbGeAlD
Methotrexate—ABCC10—medulla oblongata—Parkinson's disease	0.000622	0.00479	CbGeAlD
Methotrexate—SLC16A1—midbrain—Parkinson's disease	0.000619	0.00477	CbGeAlD
Methotrexate—SLCO3A1—nervous system—Parkinson's disease	0.000618	0.00476	CbGeAlD
Methotrexate—MTHFR—central nervous system—Parkinson's disease	0.000604	0.00466	CbGeAlD
Methotrexate—TYMS—head—Parkinson's disease	0.000604	0.00466	CbGeAlD
Methotrexate—SLC16A1—spinal cord—Parkinson's disease	0.000604	0.00465	CbGeAlD
Methotrexate—DHFR—head—Parkinson's disease	0.000598	0.00461	CbGeAlD
Methotrexate—SLCO3A1—central nervous system—Parkinson's disease	0.000595	0.00458	CbGeAlD
Methotrexate—MTHFR—cerebellum—Parkinson's disease	0.000591	0.00455	CbGeAlD
Methotrexate—SLCO3A1—cerebellum—Parkinson's disease	0.000581	0.00448	CbGeAlD
Methotrexate—PGD—head—Parkinson's disease	0.000575	0.00443	CbGeAlD
Methotrexate—TYMS—nervous system—Parkinson's disease	0.000573	0.00441	CbGeAlD
Methotrexate—ABCC10—midbrain—Parkinson's disease	0.000569	0.00438	CbGeAlD
Methotrexate—DHFR—nervous system—Parkinson's disease	0.000567	0.00437	CbGeAlD
Methotrexate—ABCC10—spinal cord—Parkinson's disease	0.000555	0.00428	CbGeAlD
Methotrexate—TYMS—central nervous system—Parkinson's disease	0.000552	0.00425	CbGeAlD
Methotrexate—DHFR—central nervous system—Parkinson's disease	0.000546	0.00421	CbGeAlD
Methotrexate—PGD—nervous system—Parkinson's disease	0.000545	0.0042	CbGeAlD
Methotrexate—TYMS—cerebellum—Parkinson's disease	0.000539	0.00415	CbGeAlD
Methotrexate—SLC16A1—head—Parkinson's disease	0.000537	0.00414	CbGeAlD
Methotrexate—SLCO1C1—brain—Parkinson's disease	0.000537	0.00414	CbGeAlD
Methotrexate—SLCO1A2—medulla oblongata—Parkinson's disease	0.000536	0.00413	CbGeAlD
Methotrexate—DHFR—cerebellum—Parkinson's disease	0.000534	0.00411	CbGeAlD
Methotrexate—PGD—central nervous system—Parkinson's disease	0.000525	0.00405	CbGeAlD
Methotrexate—PGD—cerebellum—Parkinson's disease	0.000513	0.00395	CbGeAlD
Methotrexate—SLC16A1—nervous system—Parkinson's disease	0.000509	0.00392	CbGeAlD
Methotrexate—SLC22A7—brain—Parkinson's disease	0.000509	0.00392	CbGeAlD
Methotrexate—ABCC3—head—Parkinson's disease	0.000496	0.00382	CbGeAlD
Methotrexate—SLC22A6—brain—Parkinson's disease	0.000491	0.00379	CbGeAlD
Methotrexate—SLCO1A2—midbrain—Parkinson's disease	0.00049	0.00378	CbGeAlD
Methotrexate—SLC16A1—central nervous system—Parkinson's disease	0.00049	0.00378	CbGeAlD
Methotrexate—MTHFR—brain—Parkinson's disease	0.00048	0.0037	CbGeAlD
Methotrexate—SLC16A1—cerebellum—Parkinson's disease	0.000479	0.00369	CbGeAlD
Methotrexate—SLCO1A2—spinal cord—Parkinson's disease	0.000478	0.00369	CbGeAlD
Methotrexate—SLCO3A1—brain—Parkinson's disease	0.000472	0.00364	CbGeAlD
Methotrexate—ABCC3—nervous system—Parkinson's disease	0.00047	0.00362	CbGeAlD
Methotrexate—ABCC3—central nervous system—Parkinson's disease	0.000452	0.00349	CbGeAlD
Methotrexate—AOX1—cerebellum—Parkinson's disease	0.000452	0.00348	CbGeAlD
Methotrexate—ABCC10—cerebellum—Parkinson's disease	0.00044	0.00339	CbGeAlD
Methotrexate—TYMS—brain—Parkinson's disease	0.000438	0.00337	CbGeAlD
Methotrexate—DHFR—brain—Parkinson's disease	0.000434	0.00334	CbGeAlD
Methotrexate—SLCO1A2—head—Parkinson's disease	0.000425	0.00328	CbGeAlD
Methotrexate—PGD—brain—Parkinson's disease	0.000417	0.00321	CbGeAlD
Methotrexate—ABCC4—head—Parkinson's disease	0.000409	0.00315	CbGeAlD
Methotrexate—SLC22A8—head—Parkinson's disease	0.000406	0.00313	CbGeAlD
Methotrexate—SLCO1A2—nervous system—Parkinson's disease	0.000403	0.00311	CbGeAlD
Methotrexate—SLC16A1—brain—Parkinson's disease	0.000389	0.003	CbGeAlD
Methotrexate—SLCO1A2—central nervous system—Parkinson's disease	0.000388	0.00299	CbGeAlD
Methotrexate—ABCC4—nervous system—Parkinson's disease	0.000388	0.00299	CbGeAlD
Methotrexate—SLC22A8—nervous system—Parkinson's disease	0.000385	0.00296	CbGeAlD
Methotrexate—SLCO1A2—cerebellum—Parkinson's disease	0.000379	0.00292	CbGeAlD
Methotrexate—ABCC4—central nervous system—Parkinson's disease	0.000373	0.00288	CbGeAlD
Methotrexate—SLC22A8—central nervous system—Parkinson's disease	0.00037	0.00285	CbGeAlD
Methotrexate—AOX1—brain—Parkinson's disease	0.000367	0.00283	CbGeAlD
Methotrexate—ABCG2—medulla oblongata—Parkinson's disease	0.000364	0.00281	CbGeAlD
Methotrexate—ABCC3—brain—Parkinson's disease	0.000359	0.00277	CbGeAlD
Methotrexate—ABCC10—brain—Parkinson's disease	0.000357	0.00275	CbGeAlD
Methotrexate—ABCG2—midbrain—Parkinson's disease	0.000333	0.00257	CbGeAlD
Methotrexate—ABCG2—spinal cord—Parkinson's disease	0.000325	0.0025	CbGeAlD
Methotrexate—ABCC1—cerebellum—Parkinson's disease	0.000311	0.0024	CbGeAlD
Methotrexate—SLCO1A2—brain—Parkinson's disease	0.000308	0.00237	CbGeAlD
Methotrexate—ALB—brain—Parkinson's disease	0.000306	0.00236	CbGeAlD
Methotrexate—ABCC4—brain—Parkinson's disease	0.000296	0.00228	CbGeAlD
Methotrexate—SLC22A8—brain—Parkinson's disease	0.000294	0.00227	CbGeAlD
Methotrexate—ABCB1—embryo—Parkinson's disease	0.000281	0.00217	CbGeAlD
Methotrexate—ABCG2—cerebellum—Parkinson's disease	0.000258	0.00199	CbGeAlD
Methotrexate—ABCC1—brain—Parkinson's disease	0.000253	0.00195	CbGeAlD
Methotrexate—ABCB1—forebrain—Parkinson's disease	0.000249	0.00192	CbGeAlD
Methotrexate—ABCB1—cardiovascular system—Parkinson's disease	0.00021	0.00162	CbGeAlD
Methotrexate—ABCG2—brain—Parkinson's disease	0.000209	0.00161	CbGeAlD
Methotrexate—ABCB1—medulla oblongata—Parkinson's disease	0.00018	0.00138	CbGeAlD
Methotrexate—ABCB1—midbrain—Parkinson's disease	0.000164	0.00127	CbGeAlD
Methotrexate—ABCB1—spinal cord—Parkinson's disease	0.00016	0.00123	CbGeAlD
Methotrexate—ABCB1—head—Parkinson's disease	0.000142	0.0011	CbGeAlD
Methotrexate—ABCB1—nervous system—Parkinson's disease	0.000135	0.00104	CbGeAlD
Methotrexate—ABCB1—central nervous system—Parkinson's disease	0.00013	0.001	CbGeAlD
Methotrexate—ABCB1—cerebellum—Parkinson's disease	0.000127	0.000979	CbGeAlD
Methotrexate—ABCB1—brain—Parkinson's disease	0.000103	0.000795	CbGeAlD
Methotrexate—MTHFR—Metabolism—ABCB1—Parkinson's disease	2.55e-05	0.00013	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.54e-05	0.00013	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CYP2D6—Parkinson's disease	2.54e-05	0.000129	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—CYP2E1—Parkinson's disease	2.53e-05	0.000129	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—DDC—Parkinson's disease	2.52e-05	0.000129	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.51e-05	0.000128	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—NQO1—Parkinson's disease	2.5e-05	0.000127	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—FGB—Parkinson's disease	2.5e-05	0.000127	CbGpPWpGaD
Methotrexate—ALB—Metabolism—NDUFB11—Parkinson's disease	2.49e-05	0.000127	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CTGF—Parkinson's disease	2.49e-05	0.000127	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—ABCB1—Parkinson's disease	2.49e-05	0.000127	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	2.48e-05	0.000126	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—GSTM1—Parkinson's disease	2.47e-05	0.000126	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—CYCS—Parkinson's disease	2.47e-05	0.000126	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—TH—Parkinson's disease	2.46e-05	0.000126	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—TNF—Parkinson's disease	2.45e-05	0.000125	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—MCCC1—Parkinson's disease	2.45e-05	0.000125	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ND3—Parkinson's disease	2.45e-05	0.000125	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PLA2G6—Parkinson's disease	2.44e-05	0.000124	CbGpPWpGaD
Methotrexate—MTHFR—Disease—APOE—Parkinson's disease	2.43e-05	0.000124	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—GSTM1—Parkinson's disease	2.41e-05	0.000123	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—MAOB—Parkinson's disease	2.41e-05	0.000123	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.41e-05	0.000123	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—COMT—Parkinson's disease	2.4e-05	0.000122	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—GSTP1—Parkinson's disease	2.39e-05	0.000122	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—MAOA—Parkinson's disease	2.38e-05	0.000122	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GSTA4—Parkinson's disease	2.38e-05	0.000121	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GCH1—Parkinson's disease	2.38e-05	0.000121	CbGpPWpGaD
Methotrexate—AOX1—Disease—APOE—Parkinson's disease	2.37e-05	0.000121	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—GPX1—Parkinson's disease	2.37e-05	0.000121	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—CYCS—Parkinson's disease	2.37e-05	0.000121	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—HMOX1—Parkinson's disease	2.36e-05	0.00012	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CYP2E1—Parkinson's disease	2.32e-05	0.000118	CbGpPWpGaD
Methotrexate—DHFR—Disease—MTHFR—Parkinson's disease	2.32e-05	0.000118	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PLA2G6—Parkinson's disease	2.32e-05	0.000118	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—GPX1—Parkinson's disease	2.31e-05	0.000118	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—TALDO1—Parkinson's disease	2.31e-05	0.000118	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—OMD—Parkinson's disease	2.31e-05	0.000118	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.3e-05	0.000117	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—NQO1—Parkinson's disease	2.29e-05	0.000117	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—MAOB—Parkinson's disease	2.29e-05	0.000117	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CYP2D6—Parkinson's disease	2.29e-05	0.000117	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	2.28e-05	0.000116	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—IL6—Parkinson's disease	2.27e-05	0.000116	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—ABCB1—Parkinson's disease	2.26e-05	0.000115	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—TH—Parkinson's disease	2.26e-05	0.000115	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CTGF—Parkinson's disease	2.25e-05	0.000115	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—GSTM1—Parkinson's disease	2.2e-05	0.000112	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—COMT—Parkinson's disease	2.19e-05	0.000112	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—NDUFB11—Parkinson's disease	2.19e-05	0.000111	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.18e-05	0.000111	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—GSTP1—Parkinson's disease	2.18e-05	0.000111	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—MAOA—Parkinson's disease	2.17e-05	0.000111	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CYCS—Parkinson's disease	2.17e-05	0.000111	CbGpPWpGaD
Methotrexate—DHFR—Disease—APOE—Parkinson's disease	2.16e-05	0.00011	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—HMOX1—Parkinson's disease	2.15e-05	0.000109	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.15e-05	0.000109	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PLA2G6—Parkinson's disease	2.15e-05	0.000109	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—MTHFR—Parkinson's disease	2.13e-05	0.000109	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—MAOB—Parkinson's disease	2.12e-05	0.000108	CbGpPWpGaD
Methotrexate—ALB—Metabolism—FBP1—Parkinson's disease	2.12e-05	0.000108	CbGpPWpGaD
Methotrexate—ALB—Metabolism—DBH—Parkinson's disease	2.12e-05	0.000108	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GBA—Parkinson's disease	2.12e-05	0.000108	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—GPX1—Parkinson's disease	2.1e-05	0.000107	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—COMT—Parkinson's disease	2.1e-05	0.000107	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CYP2E1—Parkinson's disease	2.09e-05	0.000107	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GSTP1—Parkinson's disease	2.09e-05	0.000106	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GCH1—Parkinson's disease	2.08e-05	0.000106	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—MAOA—Parkinson's disease	2.08e-05	0.000106	CbGpPWpGaD
Methotrexate—MTHFR—Disease—INS—Parkinson's disease	2.07e-05	0.000106	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—IL6—Parkinson's disease	2.07e-05	0.000106	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—NQO1—Parkinson's disease	2.07e-05	0.000106	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—ABCB1—Parkinson's disease	2.06e-05	0.000105	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—HMOX1—Parkinson's disease	2.06e-05	0.000105	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—TH—Parkinson's disease	2.04e-05	0.000104	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—APOE—Parkinson's disease	2.03e-05	0.000104	CbGpPWpGaD
Methotrexate—AOX1—Disease—INS—Parkinson's disease	2.03e-05	0.000103	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—GSTM1—Parkinson's disease	2e-05	0.000102	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CYP2D6—Parkinson's disease	1.99e-05	0.000102	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—APOE—Parkinson's disease	1.99e-05	0.000101	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—ABCB1—Parkinson's disease	1.97e-05	0.000101	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CYCS—Parkinson's disease	1.96e-05	9.99e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CTGF—Parkinson's disease	1.96e-05	9.97e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—MTHFR—Parkinson's disease	1.94e-05	9.9e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—ADRBK1—Parkinson's disease	1.94e-05	9.87e-05	CbGpPWpGaD
Methotrexate—FPGS—Disease—IL6—Parkinson's disease	1.93e-05	9.83e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—HSPA1A—Parkinson's disease	1.92e-05	9.8e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—COMT—Parkinson's disease	1.92e-05	9.8e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GSTM1—Parkinson's disease	1.92e-05	9.77e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—GPX1—Parkinson's disease	1.92e-05	9.77e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GSTP1—Parkinson's disease	1.91e-05	9.75e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—MAOA—Parkinson's disease	1.91e-05	9.73e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—HMOX1—Parkinson's disease	1.89e-05	9.62e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—FBP1—Parkinson's disease	1.86e-05	9.47e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—DBH—Parkinson's disease	1.86e-05	9.47e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GBA—Parkinson's disease	1.86e-05	9.47e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—SOD1—Parkinson's disease	1.86e-05	9.46e-05	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	1.85e-05	9.45e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—INS—Parkinson's disease	1.84e-05	9.4e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GPX1—Parkinson's disease	1.84e-05	9.36e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CYP2E1—Parkinson's disease	1.82e-05	9.29e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—ABCB1—Parkinson's disease	1.81e-05	9.23e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—APOE—Parkinson's disease	1.81e-05	9.21e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—NQO1—Parkinson's disease	1.8e-05	9.19e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CYP2D6—Parkinson's disease	1.79e-05	9.14e-05	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—CYCS—Parkinson's disease	1.78e-05	9.07e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—TH—Parkinson's disease	1.78e-05	9.06e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—ABL1—Parkinson's disease	1.77e-05	9.03e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—MTHFR—Parkinson's disease	1.77e-05	9.01e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—IGF2—Parkinson's disease	1.76e-05	8.99e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CTGF—Parkinson's disease	1.76e-05	8.97e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GSTM1—Parkinson's disease	1.76e-05	8.96e-05	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—INS—Parkinson's disease	1.74e-05	8.86e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—COMT—Parkinson's disease	1.73e-05	8.84e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GSTP1—Parkinson's disease	1.73e-05	8.8e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—MAOA—Parkinson's disease	1.72e-05	8.78e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CYCS—Parkinson's disease	1.71e-05	8.69e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CYP2D6—Parkinson's disease	1.7e-05	8.69e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—HMOX1—Parkinson's disease	1.7e-05	8.68e-05	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—INS—Parkinson's disease	1.7e-05	8.65e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—MTHFR—Parkinson's disease	1.69e-05	8.64e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GPX1—Parkinson's disease	1.68e-05	8.58e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CTGF—Parkinson's disease	1.67e-05	8.53e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—HGF—Parkinson's disease	1.66e-05	8.49e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	1.66e-05	8.48e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—APOE—Parkinson's disease	1.65e-05	8.39e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CYP2E1—Parkinson's disease	1.64e-05	8.36e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ABCB1—Parkinson's disease	1.63e-05	8.33e-05	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	1.62e-05	8.28e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—NQO1—Parkinson's disease	1.62e-05	8.27e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—TH—Parkinson's disease	1.6e-05	8.15e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GSTM1—Parkinson's disease	1.59e-05	8.09e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CYP2D6—Parkinson's disease	1.58e-05	8.05e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—APOE—Parkinson's disease	1.58e-05	8.04e-05	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	1.56e-05	7.95e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CYP2E1—Parkinson's disease	1.56e-05	7.95e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—DDC—Parkinson's disease	1.56e-05	7.94e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—MTHFR—Parkinson's disease	1.55e-05	7.92e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CTGF—Parkinson's disease	1.55e-05	7.9e-05	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	1.55e-05	7.88e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—INS—Parkinson's disease	1.54e-05	7.87e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—NQO1—Parkinson's disease	1.54e-05	7.86e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CYCS—Parkinson's disease	1.53e-05	7.82e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	1.53e-05	7.8e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GPX1—Parkinson's disease	1.52e-05	7.75e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—TH—Parkinson's disease	1.52e-05	7.74e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—COMT—Parkinson's disease	1.51e-05	7.7e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GSTP1—Parkinson's disease	1.5e-05	7.66e-05	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—IL6—Parkinson's disease	1.5e-05	7.66e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—MAOA—Parkinson's disease	1.5e-05	7.65e-05	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	1.48e-05	7.57e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—HMOX1—Parkinson's disease	1.48e-05	7.56e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GSTA4—Parkinson's disease	1.47e-05	7.49e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CYCS—Parkinson's disease	1.46e-05	7.44e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.45e-05	7.4e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—APOE—Parkinson's disease	1.45e-05	7.38e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CYP2E1—Parkinson's disease	1.44e-05	7.36e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—NQO1—Parkinson's disease	1.43e-05	7.28e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ABCB1—Parkinson's disease	1.42e-05	7.25e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—TH—Parkinson's disease	1.41e-05	7.17e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—INS—Parkinson's disease	1.41e-05	7.17e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—MTHFR—Parkinson's disease	1.4e-05	7.15e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GSTM1—Parkinson's disease	1.38e-05	7.04e-05	CbGpPWpGaD
Methotrexate—PGD—Disease—IL6—Parkinson's disease	1.37e-05	7.01e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—DDC—Parkinson's disease	1.36e-05	6.95e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—COMT—Parkinson's disease	1.36e-05	6.93e-05	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	1.36e-05	6.91e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GSTP1—Parkinson's disease	1.35e-05	6.9e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CYCS—Parkinson's disease	1.35e-05	6.88e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—MAOA—Parkinson's disease	1.35e-05	6.88e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—INS—Parkinson's disease	1.35e-05	6.87e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—HMOX1—Parkinson's disease	1.33e-05	6.8e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PLA2G6—Parkinson's disease	1.32e-05	6.75e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GPX1—Parkinson's disease	1.32e-05	6.74e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—MTHFR—Parkinson's disease	1.31e-05	6.69e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—MAOB—Parkinson's disease	1.31e-05	6.68e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—APOE—Parkinson's disease	1.31e-05	6.65e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—COMT—Parkinson's disease	1.29e-05	6.58e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GSTA4—Parkinson's disease	1.29e-05	6.57e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GSTP1—Parkinson's disease	1.29e-05	6.55e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—MAOA—Parkinson's disease	1.28e-05	6.54e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ABCB1—Parkinson's disease	1.28e-05	6.53e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—HMOX1—Parkinson's disease	1.27e-05	6.46e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.25e-05	6.36e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GSTM1—Parkinson's disease	1.24e-05	6.34e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—INS—Parkinson's disease	1.24e-05	6.3e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—APOE—Parkinson's disease	1.22e-05	6.23e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—MTHFR—Parkinson's disease	1.22e-05	6.22e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ABCB1—Parkinson's disease	1.22e-05	6.2e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	1.21e-05	6.17e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—COMT—Parkinson's disease	1.2e-05	6.1e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GPX1—Parkinson's disease	1.19e-05	6.07e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GSTP1—Parkinson's disease	1.19e-05	6.07e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—MAOA—Parkinson's disease	1.19e-05	6.05e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GSTM1—Parkinson's disease	1.18e-05	6.02e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—HMOX1—Parkinson's disease	1.17e-05	5.98e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PLA2G6—Parkinson's disease	1.16e-05	5.91e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—MAOB—Parkinson's disease	1.15e-05	5.85e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—APOE—Parkinson's disease	1.14e-05	5.79e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GPX1—Parkinson's disease	1.13e-05	5.77e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ABCB1—Parkinson's disease	1.13e-05	5.74e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—INS—Parkinson's disease	1.12e-05	5.68e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—MTHFR—Parkinson's disease	1.1e-05	5.6e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GSTM1—Parkinson's disease	1.09e-05	5.58e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GPX1—Parkinson's disease	1.05e-05	5.34e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—MTHFR—Parkinson's disease	1.04e-05	5.32e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—INS—Parkinson's disease	1.04e-05	5.32e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—APOE—Parkinson's disease	1.02e-05	5.21e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CYP2D6—Parkinson's disease	9.74e-06	4.96e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—APOE—Parkinson's disease	9.72e-06	4.96e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—INS—Parkinson's disease	9.71e-06	4.95e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—MTHFR—Parkinson's disease	9.67e-06	4.93e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CTGF—Parkinson's disease	9.56e-06	4.87e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—IL6—Parkinson's disease	9.07e-06	4.62e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—APOE—Parkinson's disease	9e-06	4.59e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CYP2E1—Parkinson's disease	8.91e-06	4.54e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—IL6—Parkinson's disease	8.85e-06	4.51e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—NQO1—Parkinson's disease	8.81e-06	4.49e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—INS—Parkinson's disease	8.74e-06	4.45e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—TH—Parkinson's disease	8.68e-06	4.42e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CYP2D6—Parkinson's disease	8.53e-06	4.35e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CTGF—Parkinson's disease	8.38e-06	4.27e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CYCS—Parkinson's disease	8.33e-06	4.25e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—INS—Parkinson's disease	8.3e-06	4.23e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—IL6—Parkinson's disease	8.06e-06	4.11e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CYP2E1—Parkinson's disease	7.8e-06	3.98e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—NQO1—Parkinson's disease	7.72e-06	3.93e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—INS—Parkinson's disease	7.69e-06	3.92e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—TH—Parkinson's disease	7.61e-06	3.88e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—COMT—Parkinson's disease	7.38e-06	3.76e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GSTP1—Parkinson's disease	7.35e-06	3.74e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—MAOA—Parkinson's disease	7.33e-06	3.74e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CYCS—Parkinson's disease	7.3e-06	3.72e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—HMOX1—Parkinson's disease	7.24e-06	3.69e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ABCB1—Parkinson's disease	6.95e-06	3.54e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GSTM1—Parkinson's disease	6.75e-06	3.44e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—COMT—Parkinson's disease	6.47e-06	3.3e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GPX1—Parkinson's disease	6.46e-06	3.3e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GSTP1—Parkinson's disease	6.44e-06	3.28e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—MAOA—Parkinson's disease	6.42e-06	3.27e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—HMOX1—Parkinson's disease	6.35e-06	3.24e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—MTHFR—Parkinson's disease	5.97e-06	3.04e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GSTM1—Parkinson's disease	5.91e-06	3.01e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GPX1—Parkinson's disease	5.66e-06	2.89e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—APOE—Parkinson's disease	5.55e-06	2.83e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—MTHFR—Parkinson's disease	5.23e-06	2.66e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—APOE—Parkinson's disease	4.87e-06	2.48e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—INS—Parkinson's disease	4.74e-06	2.42e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IL6—Parkinson's disease	4.56e-06	2.32e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—INS—Parkinson's disease	4.16e-06	2.12e-05	CbGpPWpGaD
